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Abstract 
Angiogenesis is one of the chief events both in development and postnatal pathological 
conditions. Recent extensive studies revealed the key signaling and transcriptional 
regulators of sprouting angiogenesis. Sprouting angiogenesis is a multistep process 
composed of endothelial loosening, endothelial cell migration, stalk elongation, anastomosis, 
and stabilization. Although the initial process of sprouting is triggered by soluble 
proangiogenic factors such as VEGF and FGF, the rather complicated subsequent step 
recruits many signaling and adhesion molecules which are pivotal players in autonomous 
and conditional specification in development. There is a marked similarity at the molecular 
level between embryogenic and postnatal angiogenesis. By its physiological constraint, 
endothelium differentiation is closely linked with blood cell specification. Many 
transcription factors with a major role in hematopoietic stem cell generation are also 
involved in angiogenesis. 
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Introduction
 Blood cell differentiation, blood vessel con-
struction, and the initiation of circulation comprise 
one of the most interesting fields in developmental 
biology. This is especially true because the 
formation of all organs of the human body are 
closely linked with vascular development and 
blood supply. The vascular system is charac-
terized by postnatal remodeling. Blood vessel 
remodeling and neovascularization are involved in 
many physiological process, such as endometrial 
thickening and formation of the placenta. 
Although the large vessels do not have the 
capacity for remodeling, capillaries are newly 
formed at the sites of oxygen deficiency. In 
addition, capillary growth is associated with a 
number of pathological conditions, such as the 
formation of granulation tissue in inflammatory 
disease and cancer growth. Tumor growth 
requires coordination between tumor cell pro-
liferation and increased blood supply by newly 
formed vessels. 
 Postnatal remodeling of the vascular system 
might mimic the embryonic construction of the
vascular system at a molecular level. In order to 
reveal the molecular mechanism of neovasculari-
zation, the optimal way is to look for common 
mechanisms in both embryonic and postnatal 
vascular system construction.
Embryonic construction of vascular system
  The development of blood vessels occurs by 
two temporally separate process : vasculogenesis 
and angiogenesis. During vasculogenesis, the 
common precursors of blood and endothelial cells, 
hemangioblasts, are specified de novo from the 
lateral plate mesoderm to form the capillary 
network. During angiogenesis, this primary 
capillary network is remodeled to the mature 
vascular tree. The combination of BMP, Wnt, and 
Notch signals seems to be needed for the primary 
specification of hemangioblasts, and results in 
expression of hemangioblast specific transcription 
factor Etv2, the cell surface receptor VEGF2, and 
another receptor, FGFR. The final fate deter-
mination of the hemangioblasts seems to be based 
on the amount of Notch signal, in which its 
abundance makes them blood cells and its
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scarcity endothelial cells. The major paracrine 
factors involved in vasculogenesis are FGF and 
VEGF signals. After the primary capillary plexus 
is completed, the stabilization of the endothelial 
network is accomplished using  Angl/Tie2 
signaling. In this process, pericytes which 
surround the endothelium produce  Angl. Tie2 is 
the receptor for  Angl expressed on the 
endothelial cell membrane. Upon the binding of 
 Angl, its signal strengthens the endothelial cell-
cell junction by preventing internalization of the 
junctional molecule VE-cadherin. During angio-
genesis, the VEGF signal via VEGFR2 becomes 
the main signal for the growth of blood vessels, 
and the importance of the the VEGF signal is 
conserved in postnatal angiogenesis. In the final 
step of angiogenesis, the mature circulatory 
system is constructed by recruiting pericytes. 
 TGF-  promotes the differentiation of precursor 
cells to pericytes, and PDGFR-expressing  peri-
cytes migrates in response to PDGF to surround 
the newly formed vessels.
The sites of vasculogenesis and hematopoiesis 
in embryogenesis
  In mammalian development, both the blood 
cells and vascular system are derived from the 
posterior lateral mesoderm. Especially, blood and 
endothelial cells are considered to differentiate 
from common putative precursors called  "  heman-
gioblasts". The presence of hemangioblasts has 
been well established in culture system and yolk 
sac  erythropoiesis. ES cells very efficiently 
differentiate into red blood cells in  matrigel when 
LIF is deprived of ordinary ES cell culture 
medium. Hemangioblasts can be identified during 
this process as cells with bi-potential. In mouse 
embryogenesis, blood islands form in the wall of 
the yolk sac, where primary erythrocytes are 
produced in the inner portion of blood islands 
while peripheral flat cells of the islands become 
endothelial cells. The first hematopoietic stem 
cells (HSCs) are produced in the AGM region of 
the mouse embryo. Recent extensive studies 
revealed that HSCs are derived from hemogenic 
endothelial cells of the dorsal  aorta. In extra-
embryonic hematopoiesis (yolk sac erythropoiesis, 
primary hematopoiesis), hematopoiesis and 
angiogenesis proceed in parallel. On the other 
hand, hematopoiesis depends upon angiogenesis 
(formation of dorsal aorta) in intraembryonic 
hematopoiesis (definitive hematopoiesis), because 
the dorsal aorta is constructed before the 
specification of hematopoietic stem cells from its
wall. 
 The construction of blood vessels has a phy-
siological constraint : in the developmental 
process, the vascular system should supply 
oxygen and nutrients to the developing organs 
even during its construction. This constraint 
becomes more crucial in a closed circulatory 
system. In organisms with a close circulation, the 
blood cells, the oxygen carriers, should arise in 
parallel with vascular development. The inevi-
tably common mechanism and close relationship 
between the two will be discussed later.
Sprouting angiogenesis and the key cell types
  Angiogenesis is the physiological process 
through which new blood vessels form from pre-
existing ones. Angiogenesis is classified into two 
types : sprouting angiogenesis and intussusce-
ptive angiogenesis (also known as splitting angio-
genesis). Sprouting angiogenesis is the more 
common form, its molecular mechanism has 
recently been studied extensively, and it is 
discussed mainly in this article. 
 In the process of vessel sprouting of the existing 
blood vessels, the endothelial cells of the vessels 
are specified into three types of endothelium. The 
tip cells form the migrating front of the vascular 
buds. They have filopodias protruding from their 
cell membrane, which play a role in determining 
the direction of migration and also in capillary 
anastomosis. The stalk cells are just neighboring 
the tip cells and markedly proliferates during the 
growth of the vascular stalks. These two types of 
cells characterize the  "activated endothelium", 
because they are specified by the influence of the 
proangiogenic factors at the site of sprouting. 
The third cell type of the endothelium, called 
"
phalanx  cells" is not activated during the process 
of angiogenesis and does not proliferate during 
sprouting.
Tip cell selection and the lateral inhibition
 The mouse retina presents the best model 
system to study the molecular mechanism of 
angiogenesis because angiogenesis occurs post-
natally there. The vascular system of the mouse 
retina is mainly constructed by the process of 
sprouting angiogenesis, where the sprouts 
migrate into the extracellular matrix from the 
existing blood vessels. Other in vivo and in vitro 
angiogenesis models also contribute greatly in 
order to clarify its molecular mechanism. Among 
these, the zebra fish is particularly useful for the
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time-lapse observation of vascular development. 
The genetically modified Flil-eGFP fish, expres-
sing GFP on the endothelial cells, provides an 
extremely informative model for the study of 
sprouting angiogenesis. 
 By the influence of proangiogenic factors 
(VEGF or FGF), which are usually secreted on 
oxygen and nutrient deficiency, the part of 
endothelial cells of the existing blood vessels 
differentiate into tip cells which form the single 
apex cell of the sprouting buds. They are selected 
at the site where the VEGF concentration is the 
highest. All parts of the existing capillaries' 
endothelium have the capacity to respond to the 
inductive signal of proangiogenic factors. In the 
case of VEGF signals, the endothelial cells at the 
highest concentration of VEGF receive the signal 
via membrane-bound VEGF receptors (VEGFR). 
The main VEGFR is VEGFR2 and the signal 
through VEGFR2 stimulates tip cell differen-
tiation. It is enhanced by the co-receptor  neuro-
pilinl. Vessel sprouting requires coordination 
between migrating tip cells and proliferative stalk 
cells, and the specification between tip and stalk 
cells is regulated by lateral inhibition using a 
signal through Notch. On receiving the VEGF 
signal, the tip cells express DLL4 on their 
membrane, which binds Notch on the neighboring 
endothelium. This DLL4-Notch signal results in 
the downregulation of VEGFR2/neuropilinl in the 
neighboring endothelial cells and makes them the 
less VEGF- responsive stalk cells. Thus, using 
both VEGF and the Notch signal, the specification 
of the activated endothelium into the tip and stalk 
cells is achieved. Once luminized connections are 
completed, the activated endothelial cells become 
quiescent endothelium, the phalanx cells (dis-
cussed later).
Preparation for tip cell migration
 Tip cell migration requires the following pro-
cesses : basement membrane (BM) degradation, 
endothelial cell (EC) junction loosening (VE-
cadherin), and pericyte detachment. Angio-
poietinl  (Angl) and Ang2 bind Tie2, a tyrosine 
kinase receptor expressed in the endothelium. 
Perivascular cell (pericyte) expression of  Angl 
stabilizes and tightens the inter-endothelial 
junction by increasing VE-cadherin expression on 
the endothelial cell membrane. Ang2 functions as 
a competitive antagonist of  Angl for endothelial 
junction loosening.
Sprout guidance and progression
  In neuronal guidance, a number of ligand-
receptor interactions (Eph-ephrin, netrins-Unc, 
Robo-Slit, semaphorins-plexins, and semaphorines-
neuropilins) are involved. Taking the marked 
alignment of neurons and blood vessels into 
consideration, it is not surprising that they share 
the same soluble signal for their guidance. How 
common their guidance mechanism is and their 
mutual interaction are questions attracting 
attention. VEGF again seems to be the main 
soluble factor for tip cell migration and guidance, 
and, interestingly, neuropilins are also receptors 
for VEGF in addition to semaphorins. The 
neighboring cells of tip cells  (i.  e., the stalk cells) 
express VEGFR1 which trap the VEGF, thus 
resulting in a VEGF- rich corridor in front of the 
tip cells. This enables the almost perpendicular 
growth of the tip cells from the pre-existing blood 
vessel walls.
Stalk cell proliferation
  The marked proliferation of stalk cells is 
needed for stalk elongation. However, the tip cells 
do not progress into ECM by being pushed by the 
proliferating stalk cells. On the contrary, the tip 
cells pull the stalk cells by their progress. Some 
mechanical pulling force should be transformed to 
the chemical signal on the stalk cells. The Wnt 
signal stimulates the proliferation of the stalk cells 
and the Notch signal inhibits it. In the process of 
stalk elongation, the proliferation-stimulating Wnt 
signal should override the inhibitory Notch signal. 
For that purpose, stalk cells begin to express the 
Notch target Nrarp (Notch-regulated Ankyrin 
repeat protein), which limits Notch signaling. As 
the vessels elongate, the stalk cells form a lumen 
within the cells, which eventually facilitates blood 
flow.
Vessel fusion aided by macrophages
  When tip cells of adjacent vessels meet via 
filopodia, they anastomose. The cell junction at 
the site of cell contact expands into rings, 
generating an interface of apical membrane 
compartments. In this anastomosis, macrophages 
play the connecting role for the two tip cells by 
excreting several soluble proangiogenic factors. 
The macrophages express Tie2, Notch, and 
CXCR4, which accept the soluble molecule 
presumably secreted by the anastomosing tip cell 
and function as bridging molecules for connecting
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the tip cells with VE-cadherin on their filopodias. membrane which expresses laminin- 4 in tip cells 
limits their number by inducing Notch signals.
Tip/stalk cell balance
 Alki (Activin receptor-like kinase), an EC-
specific member of the  TGF-   superfamily, is 
inactivated genetic disease hereditary hemorr-
hagic telangiectasia (HHT).  Smadl/5, an  Alkl 
downstream transduction molecule, plays the 
most important roles in the Tip/Stalk balance. 
The resulting  Smadl/5 loss impairs Notch 
signaling, which results in the increased tip cell 
selections and, therefore, over-branching blood 
vessels. The appropriate distribution of the tip 
cells is one of the most important mechanisms for 
effective post-natal angiogenesis by determining 
the number of branches of the vascular tree and 
also the diameter of each blood vessels.
Lumen formation
 A second important role of the stalk cells within 
a newly forming blood vessel is to establish a 
vascular lumen. The unique mechanism of lumen 
formation was observed in zebra fish ISV (inter-
somitic vessel) development, in which the 
vascular lumen of ISVs is formed by the fusion of 
intercellular vacuoles. These vacuoles coalesce to 
eventually form the continuous route for the blood 
stream.
Vessel maturation
 Mural pericyte attachment surrounding the 
nascent blood vessels is necessary for blood vessel 
maturation. As discussed previously,  TGF-  
promotes the mesenchymal precursor cells to 
differentiate into pericytes, and PDGFR-
expressing pericytes migrate in response to 
PDGF to surround the newly formed vessels. 
 Angl is secreted from the pericytes to strengthen 
the inter-endothelial junction and, thus, contribute 
to the stabilization of the nascent blood vessels.
Resuming quiescence in endothelial cells
 Phalanx cells represent the quiescent cells in 
angiogenesis. After oxygen and nutrient satura-
tion provided by the newly formed blood vessel, 
the level of the proangiogenic factors is decreased. 
The withdrawal of the proangiogenic factors and 
increased pro-quiescent molecules lead to stabili-
zation of the nascent endothelium. Autocrine 
signals of VEGF,  Angl, FGF, and Notch maintain 
the endothelium in quiescence. The basement
The transcriptional regulation of angiogenesis 
and hematopoiesis by Lmo2
 As mentioned before, in development, angio-
genesis is closely linked with hematopoiesis. FGF 
inductive signal results in the hemangioblast-
specific transcription factor Etv2. The expression 
of Etv2 then triggers the hematopoiesis/ 
angiogenesis transcription factor Lmo2. The 
oncogenic LIM domain transcription factor Lmo2 
is necessary for definitive hematopoiesis in 
addition to yolk sac erythropoiesis (Yamada et al. 
1998). Lmo2 has no DNA binding capacity but 
forms a transcription factor complex through its 
two tandemly arranged LIM domains. It has been 
shown to bind to other DNA binding protein such 
as GATA1/2/3, Tall, and Lyll and form a 
transcription factor complex. Lmo2 also plays a 
pivotal role in embryonic angiogenesis (Yamada 
et al., 2000). In the event of the first specification 
of HSCs, the transcription factor complex 
including Lmo2 (the Lmo2 complex) promotes the 
angiogenic process in the mouse AGM region and 
is involved in the specification of blood cells from 
the dorsal aorta endothelium by triggering the 
upregulation of the appropriate downstream 
genes. The mouse vascular system is also con-
structed by two consecutive processes : vasculo-
genesis and angiogenesis. Without the Lmo2 
transcriptional signal, this sprouting angiogenesis 
process is completely abolished, although 
vasculogenesis, the specification of hemangio-
blasts is not affected (Yamada et al.,  2000  ;
Yamada et al., 2002).
The downstream molecules activated by Lmo2
 Recently, Lmo2 transcriptional signals have 
been examined in detail, and several Lmo2 
downstream genes which are considered to have 
pivotal roles in sprouting angiogenesis have been 
clarified. VE-cadherin, angiopoietin2, neuropilin2 
(VEGF receptor), and  TGF-  are direct Lmo2 
target genes, and most VEGF receptors are 
upregulated by the expression of Lmo2. The 
Lmo2 complex (discussed in detail later) regulates 
sprouting angiogenesis via these soluble factors, 
its receptors, and adhesion molecules. 
 In summary, the FGF signal mainly specifies 
the hemato-vasculogenic mesoderm by transcrip-
tionally activating Etv2. Then, this transcription 
factor activates Lmo2, Tall, and Gata2 which have
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 key roles both in hematopoiesis and angiogenesis. 
 The Lmo2 complex formed by Lmo2, Tall, and 
 Gata2 determines the hemogenic endothelium in 
 the dorsal aorta endothelial cells. In embryo-
 genesis, this hemogenic endothelium differen-
 tiates the hematopoietic stem cells by expressing 
 Runxl transcription factor and c-kit membrane 
 bound receptor. Another important role of this 
 Lmo2 transcription factor complex is angio-
 genesis, although the Lmo2 binding partners have 
 not been fully identified. Of course, angiogenesis 
 is necessary for the construction of large blood 
 vessels such as the dorsal aorta, which is the first 
 intraembryonic hemogenic site. The angiogenic 
 role of the Lmo2 complex should be performed 
 immediately after the specification of heman-
 gioblasts. It could be either before or after the 
 specification of the hemogenic endothelium in the 
 dorsal aorta.
Multistep angiogenesis by Lmo2 downstream 
molecules
 The process of sprouting angiogenesis from the 
existing blood vessels can be divided into several 
steps, as mentioned. In each step, Lmo2 down-
stream genes are involved, as shown below. Key 
players are indicated in each step and Lmo2 
complex target molecules are underlined. 
 (1) ECM remodeling and pericyte detach-
     ment : angiopoitin-2  
 (2) Loosening endothelial junction : VE-
    cadherin  
 (3) Tip cell formation and migration : VEGF 
     and its receptors  
 (4) Stalk elongation and tip cell  guidance  :
     Semaphorines and neoropilin 
 (5) Endothelial junction formation : VE-
    cadherin  
 (6) Pericyte recruitment and its  maturation  :
 angiopoitin-1 and  TGF-   
 Obviously, the Lmo2 complex transcriptional 
signal orchestrates the whole sprouting process. 
Gata2 and Lmo2 regulate angiogenesis and 
lymphangiogenesis cooperatively 
 Thomas Graf presented the "cocktail party 
model" for transcription factor complex transition 
in the progression of blood cell specification. 
According to the model, the hematopoietic 
transcription factor complex changes gradually, 
by one joining and another leaving, in each stage 
of blood cell differentiation to construct the entire 
blood cell system. At that time, the Lmo2
complex itself was one of the strong candidates 
for this complex, especially in hematopoietic stem 
cell differentiation into progenitor blood cells. 
 Now, there is strong evidence that the Lmo2 
complex also plays key roles in the process of 
angiogenesis. As mentioned, Gata2 and Lmo2 
form common transcription complexes during 
hematopoietic differentiation by direct interaction 
between the two molecules. These two 
transcription factors also play a key role in 
endothelial cells and lymphatic endothelial cell 
function cooperatively. Silencing of Lmo2 and 
Gata2 expression by siRNA inhibited VEGF-
induced angiogenic activity including endothelial 
migration and sprouting in vitro (Coma et al., 
2013). Interestingly, the knockdown of both Lmo2 
and Gata2 completely blocks the vessel sprouting 
and all the VEGF receptors including VEGFR2 
are downregulated. This inhibition of the endo-
thelium is also associated with the downregu-
lation of another VEGF receptor, neuropilin2. A 
Chip study clearly showed that neuropilin2 is the 
downstream molecule of the transcription factor 
complex composed of Lmo2 and Gata2. In a 
previous section, the phenotypes of the  Lmo2-KO 
mouse were discussed. Those of the  Gata2-KO 
mouse are markedly similar to the defects of the 
 Lmo2-KO mouse and its defects in hematopoiesis 
(lack of hematopoietic stem cells), angiogenesis, 
and lymphangiogenesis. Both transcription 
factors are strongly expressed in the endothelial 
cells.
Conclusion : Cocktail party model for sprout-
ing angiogenesis 
  The first hematopoietic stem cell (HSC) 
emerges from the wall of the dorsal  aorta. The 
site of emergence of HSC is the hemogenic 
endothelium, which constitutes a part of the 
arterial wall endothelium. The key transcription 
factor complex characterizing the hemogenic 
endothelium is the Lmo2 complex :  Tall-Lmo2-
Gata2. The basic helix-loop-helix transcription 
factor Tall is expressed in the static (quiescent, 
not activated) endothelium. In the process of 
vessel sprout, Tall is downregulated in the 
activated endothelium. On the other hand, Lmo2 
and Gata2 are slightly upregulated in the 
activated endothelium. Therefore, the putative 
Lmo2 transcription factor complex composition in 
the activated endothelium is  Gata2-Lmo2-Lmo2-
Gata2. Further studies are needed for the 
identification of the tip and stalk cell-specific 
transcription factors. The Lmo2 complex is, of
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course, one of the candidates.
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